Genetic Literacy Project
‘It’s not super useful’: As wariness about AI grows, Trump proposes rollback of healthcare safeguards
Paul Boyer, a psychotherapist for Kaiser Permanente in Oakland, California, is experiencing the AI revolution firsthand. He’s a little underwhelmed ...
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
Every administration says it prioritizes getting the science right, and our current Administration has emphasized using “gold-standard science” as the ...
Facts & Fallacies Podcast: Nicotine vaping—public health miracle, or risk to children? Professor Cliff Douglas
E-cigarettes burst onto the scene nearly 20 years, disrupting the cigarette industry and leaving anti-smoking advocates uncertain about how to ...
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state
“On behalf of President Donald J. Trump,” read 22 emails sent from the White House Presidential Personnel Office on Friday afternoon, April ...
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
The famous Orange Bowl may still host an annual New Year’s Day football game after 91 years in celebration of ...
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
NAD has been discussed in the wellness world for years. In 2019, Jennifer Aniston mentioned it in an interview with ...
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
Information, much of it false, spreads at lightning speed in today’s digital age. The problem is more troubling than it ...
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
As we recently argued, the American healthcare system’s structure of open-ended reimbursement, subjective diagnostic criteria, and fee-for-service billing creates powerful ...
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
Artificial intelligence (AI) is increasingly being integrated into health care, including but not limited to diagnosis and treatment plans, drug development, prediction of health risks and ...
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Corrupt and Unethical Leadership at the FDA There is a particular kind of government betrayal that arrives not with a ...
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe
In 2000, three researchers published a peer-reviewed paper concluding that, “under present and expected conditions of use,” Roundup, a formulation of ...
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
[T]he chasm between what gets said on Capitol Hill and what actually ends up playing out in policy has never ...
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Artificial intelligence (AI) has made major advances in biomedical research. It has powered tools such as AlphaFold and systems that ...
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
In the competitive food marketplace, fear-based marketing continues to be a go-to strategy for some food companies trying to differentiate ...
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Clickbait headlines often obscure this reality and reinforce misunderstandings. For example, cancer is not a single disease; it’s a catchall ...
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Science communications is not an easy task. You have to be comprehensive and concise, simplifying the message while not dumbing ...
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Fossil fuels, pesticides and food processing have dramatically improved living standards around the globe. This may be a controversial claim, ...
Regulators’ dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Umpiring in sport is a strange profession. A cricket umpire stands for hours under the sun, matching the stamina of ...
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
The political momentum behind costly climate-change mitigation appears to be weakening, especially in the United States. President Donald Trump has ...
Science Disinformation Gap: The transatlantic battle over social media and censorship
Every day, the same post appears in two places at once. A Facebook user in Munich sees it with a ...
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
They are newborns, many of them less than two weeks old, and the race to save them is measured in ...
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
In July 2025, the US Food and Drug Administration (FDA) announced a pilot program intended to expedite reviews for drug ...
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging
When United States Health Secretary Robert F. Kennedy Jr. unveiled new dietary guidelines earlier this year to “Make America Healthy ...
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
For decades, nutrition advice on carbohydrate-rich foods has offered a simple way to enjoy carbs guilt-free: no need to give ...
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Eman, our informally adopted son who is a physician in Monrovia, Liberia, is recovering from the measles. He contracted it ...
GLP podcast: ‘Safe injection sites’: enabling drug addiction or saving lives?
With illicit opioids still killing thousands of Americans each year, some public health advocates are pushing a radical solution to ...
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Food and Drug Administration (FDA) Commissioner Marty Makary recently stated that when it comes to drugs that currently require a ...
